TUBB3
protein-codingtubulin beta 3 class III, the group of Tubulins
Gene summary
This gene encodes a class III member of the beta tubulin protein family. Beta tubulins are one of two core protein families (alpha and beta tubulins) that heterodimerize and assemble to form microtubules. This protein is primarily expressed in neurons and may be involved in neurogenesis and axon guidance and maintenance. Mutations in this gene are the cause of congenital fibrosis of the extraocular muscles type 3. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 6. [provided by RefSeq, Oct 2010]
- FEOM3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0013541
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0013541
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0100154
Submitter: ClinGen
*TUBB3* encodes neuron-specific β-tubulin isotype III which is the most dynamic tubulin within the β-tubulin family (PMID: 20074521). *TUBB3* was first reported in relation to tubulopathies in 2010 (Tischfield et al., PMID: 20074521). *TUBB3*-related tubulinopathy is characterized by malformations of cortical development, axon guidance defects, white matter abnormalities, and/or congenital fibrosis of the extraocular muscles (CFEOM) due to heterozygous *de novo* or inherited variants with high penetrance. Individuals may present with variable combinations of malformations of cortical development, dysplasia of the basal ganglia, brainstem, and/or cerebellum, CFEOM, additional cranial nerve involvement, Kallmann syndrome, cyclic vomiting, peripheral neuropathy, and/or contractures. Developmental delays, intellectual disability, ocular motor apraxia, and mirror movements are also frequent features. Multiple missense variants, most of which were *de novo*, reported in over 20 probands across 12 publications (PMIDs: 20829227, 26639658, 34562182, 20074521, 28503613, 26130693, 28299356, 34863918, 29187032, 34869359, 26739025, 32573066) and one additional proband from the Brain Gene Registry (braingeneregistry.wustl.edu; ClinVar ID: SCV002103326.1) are included in this curation. This gene-disease relationship is also supported by experimental evidence. *TUBB3* is within the β-tubulin family with the genes *TUBB2A* and *TUBB2B* which have been definitively implicated in conditions (tubulinopathy and complex cortical dysplasia with other brain malformations, respectively) with overlapping phenotypes (PMID: 35915025). Additionally, a R262C knock-in mouse model showed defects in the guidance of axons throughout the brain and a thinning of the anterior commissure similar to human patients (PMID: 20074521). Lastly, cells with the variants R262C, A302T, R62Q, and R380C demonstrated increases in microtubule stabilization and increased time in “paused” states compared to wild-type (PMID: 20074521). The mechanism of pathogenicity appears to be gain-of-function (PMID: 20074521). In summary, there is definitive evidence supporting the relationship between *TUBB3* and autosomal dominant TUBB3-related tubulinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism GCEP on September 8, 2022 (SOP 9).
Inheritance Pattern: AD
Disease ID:MONDO:0010912
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0013541
Submitter: Illumina
Inheritance Pattern: AD
Disease ID:MONDO:0007614
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0010912
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0018763
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0013541
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0013541
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0010912
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0010912
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TUBB3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006086.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 96 | 3 | 104 | ||
| missense | 15 | 58 | 162 | 9 | 3 | 247 |
| nonsense | 6 | 6 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 15 | 58 | 175 | 105 | 6 | 359 |
Highest pathogenic variant AF is 0.0000065713384
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006077.2 | 4 | MANE Select | |
| Ensembl | ENSP00000320295.7 | 4 | MANE Select | |
| RefSeq | NP_001184110.1 | 2 | Standard | |
| Ensembl | ENSP00000452001.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Phagosome - Homo sapiens (human)
- Gap junction - Homo sapiens (human)
- Pathogenic Escherichia coli infection - Homo sapiens (human)
- Pathogenic Escherichia coli infection
- Parkin-Ubiquitin Proteasomal System pathway
Biological Process
- microtubule cytoskeleton organization
- mitotic cell cycle
- microtubule-based process
- axon guidance
- neuron differentiation
Molecular Function
- GTPase activity
- structural constituent of cytoskeleton
- protein binding
- GTP binding
Cellular Component
- nucleus
- cytoplasm
- microtubule
- axon
- dendrite
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000315491
- Coding exons
- 4
- Length
- 17370
- Individuals with no LoFs
- 125709
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 3
- Defined
- 125712
- p
- 0.0000119
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.58 | 77 | 300 | 0.256 | 0.0000234 | 2991 |
| Missense (PolyPhen) | 14 | 123.86 | 0.11303 | 1323 | ||
| Synonymous | -2.22 | 172 | 139 | 1.24 | 0.0000130 | 879 |
| Loss of Function | 3.36 | 1 | 15.0 | 0.0665 | 7.29e-7 | 163 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain. TUBB3 plays a critical role in proper axon guidance and mantainance. {ECO:0000269|PubMed:20074521}.;
- Disease
- DISEASE: Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638]: A congenital ocular motility disorder marked by restrictive ophthalmoplegia affecting extraocular muscles innervated by the oculomotor and/or trochlear nerves. It is clinically characterized by anchoring of the eyes in downward gaze, ptosis, and backward tilt of the head. Congenital fibrosis of extraocular muscles type 3 presents as a non-progressive, autosomal dominant disorder with variable expression. Patients may be bilaterally or unilaterally affected, and their oculo-motility defects range from complete ophthalmoplegia (with the eyes fixed in a hypo- and exotropic position), to mild asymptomatic restrictions of ocular movement. Ptosis, refractive error, amblyopia, and compensatory head positions are associated with the more severe forms of the disorder. In some cases, the ocular phenotype is accompanied by additional features including developmental delay, corpus callosum agenesis, basal ganglia dysmorphism, facial weakness, polyneuropathy. {ECO:0000269|PubMed:20074521}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039]: A disorder of aberrant neuronal migration and disturbed axonal guidance. Affected individuals have mild to severe mental retardation, strabismus, axial hypotonia, and spasticity. Brain imaging shows variable malformations of cortical development, including polymicrogyria, gyral disorganization, and fusion of the basal ganglia, as well as thin corpus callosum, hypoplastic brainstem, and dysplastic cerebellar vermis. Extraocular muscles are not involved. {ECO:0000269|PubMed:20829227}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.701
Intolerance Scores
- LoFtool
- 0.244
- RVIS EVS
- -0.76
- RVIS percentile EVS
- 13.33
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.927
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |